Tata Consultancy Services Ltd.

BSE: 532540 | NSE: TCS
Large Cap | IT - Software
3185.15
60.10 (1.92%)
< Home < Back

TCS features as ‘Leader and Star Performer’ in Everest Group report

Date: 19-08-2017

Tata Consultancy Services (TCS) has been recognized as a Leader and Star Performer for Life Sciences Clinical and R&D IT Services by leading advisory and research firm, Everest Group, in its report, ‘Life Sciences Clinical and R&D IT Services - Service Provider Landscape with PEAK Matrix Assessment 2017.’

Everest Group acknowledged TCS’ strong foothold in the pharmaceutical and medical devices sector and a growing business presence with biotechnology firms. The report highlights TCS’ strong growth in strategic clinical and R&D space with solutions such as Advanced Drug Development Platform and Connected Clinical Trials and consistent execution excellence. In addition, the company is recognized for its significant investments in gene-based therapeutics and connected healthcare and an emerging platform play in clinical and R&D areas.

Tata Consultancy Services (TCS) is an IT services, consulting and business solutions organization that delivers real results to global business, ensuring a level of certainty no other firm can match. The company offers a consulting-led, integrated portfolio of IT, BPS, infrastructure, engineering and assurance services.